Phase II Study of Pentostatin in Patients With Corticosteroid-Refractory Chronic Graft-Versus-Host Disease

David A. Jacobsohn, Allen Chen, Marianna Zahurak, +7

Journal of Clinical Oncology

Histiocytic Neoplasms, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology

Ronald S. Go, Eric D. Jacobsen, Robert A. Baiocchi, +22

Journal of the National Comprehensive Cancer Network

Pearson marrow pancreas syndrome in patients suspected to have Diamond-Blackfan anemia

Katelyn E. Gagne, Roxanne Ghazvinian, Daniel Yuan, +17

Blood

Epstein-Barr virus DNA in serum as an early prognostic marker in children and adolescents with Hodgkin lymphoma

Jennifer Welch, Cindy L. Schwartz, Meghan A. Higman, +7

Blood Advances

Hematological MalignancyLymphoid NeoplasiaHodgkin LymphomaEarly Prognostic MarkerEpstein-barr Virus +13

Treatment of hepatitis‐associated aplastic anemia with high‐dose cyclophosphamide

William Savage, Patricia A. DeRusso, Linda Resar, +5

Pediatric Blood & Cancer

Successful treatment of a child with late onset T‐cell post‐transplant lymphoproliferative disorder/lymphoma

Kirsten M. Williams, Meghan A. Higman, Allen Chen, +4

Pediatric Blood & Cancer

A Clinical Algorithm Identifies High Risk Pediatric Oncology and Bone Marrow Transplant Patients Likely to Benefit From Treatment of Adenoviral Infection

Kirsten M. Williams, Allison L. Agwu, Alix Dabb, +4

Journal of Pediatric Hematology/Oncology

AHOD0031: A Phase III Study of Dose-Intensive Therapy for Intermediate Risk Hodgkin Lymphoma: A Report From the Children's Oncology Group

Debra L. Friedman, Suzanne L. Wolden, Louis S. Constine, +13

Blood

Low toxicity and favorable overall survival in relapsed/refractory B-ALL following CAR T cells and CD34-selected T-cell depleted allogeneic hematopoietic cell transplant

Vanessa A. Fabrizio, Nancy A. Kernan, Farid Boulad, +15

Bone Marrow Transplantation

Car T CellsCell TherapyTransplantationLow ToxicityMedicine +10

Reduced-Intensity Conditioning with Fludarabine, Melphalan, and Total Body Irradiation for Allogeneic Hematopoietic Cell Transplantation: The Effect of Increasing Melphalan Dose on Underlying Disease and Toxicity

George L. Chen, Theresa Hahn, Gregory E. Wilding, +14

Biology of Blood and Marrow Transplantation